BioGX

BioGX is a molecular diagnostics company with offices in Birmingham's Innovation Depot. The company also operates a second manufacturing and distribution center, BioGX BV, in Amsterdam, the Netherlands.

BioGX was founded in 2007 by Michael Vickery. Shazi Iqbal has served as CEO since 2011. Both are veterans of the Sunnyvale, California-based Cepheid Inc.

BioGX partnered with Becton Dickinson & Co. of New Jersey to develop a rapid COVID-19 RNA test for its "BD Max" diagnostic platform. The test was granted an emergency use authorization from the U.S. Food and Drug Administration in April 2020.

References

• Patchen, Tyler (March 17, 2020) "Birmingham biotech firm collaborating on COVID-19 diagnostics." Birmingham Business Journal
• Patchen, Tyler (April 6, 2020) "Bham biotech firm's COVID-19 test collaboration gets FDA authorization." Birmingham Business Journal

External links

• BioGX website